Atlas Trials

Secondary Prevention Trial of Rapamycin in Patients With Resected Non-muscle Invasive Bladder Cancer

Clinical trial NCT03298958 · WITHDRAWN

Trial details

NCT number
NCT03298958
Sponsor
The University of Texas Health Science Center at San Antonio
Status
WITHDRAWN
Phase
Phase 3
Study type
INTERVENTIONAL
Bladder Cancer
Start date
2018-11-01
Primary completion
2022-02-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.